Aegis Sciences Corporation has achieved great success with its sales and service according to our latest Client Satisfaction Survey. Our...
NASHVILLE, Tenn., July 1, 2023 – Aegis is pleased to announce that following a rigorous review process, it will continue to...
Aegis recent panelist, Ryan S. Alexander, DO, MPH, has released an op-ed where he expresses the need for testing in...
Aegis provider and recent panelist, Leigh Brooks, APRN, FNP-C, has released an op-ed where she shares her firsthand experience with...
Aegis Clinical Pharmacist, Andrew Holt, Pharm.D., BCMAS, CPGx, has released an op-ed where he expresses the importance of clinical definitive...
The Biden Administration recently designated the fentanyl-xylazine combination as an emerging national threat. Aegis Sciences Corporation in Nashville has been...
Sign up for the Aegis Newsletter